Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
5.25
+0.18 (3.45%)
Mar 14, 2025, 2:35 PM EDT - Market open
Myomo Revenue
In the year 2024, Myomo had annual revenue of $32.55M with 69.17% growth. Myomo had revenue of $12.07M in the quarter ending December 31, 2024, with 153.73% growth.
Revenue (ttm)
$32.55M
Revenue Growth
+69.17%
P/S Ratio
5.88
Revenue / Employee
$307,087
Employees
106
Market Cap
174.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32.55M | 13.31M | 69.17% |
| Dec 31, 2023 | 19.24M | 3.69M | 23.70% |
| Dec 31, 2022 | 15.56M | 1.70M | 12.26% |
| Dec 31, 2021 | 13.86M | 6.27M | 82.72% |
| Dec 31, 2020 | 7.58M | 3.75M | 97.60% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
MYO News
- 3 days ago - Myomo, Inc. (MYO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million - Business Wire
- 10 days ago - Myomo to Report Fourth Quarter 2024 Financial Results on March 10 - Business Wire
- 3 months ago - Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock - Business Wire
- 3 months ago - Myomo, Inc. Announces Proposed Public Offering of Common Stock - Business Wire
- 4 months ago - Myomo, Inc. (MYO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Myomo Reports Record Third Quarter Financial and Operating Results - Business Wire
- 4 months ago - CMS Decision And O&P Network Build Out Make Myomo A Buy - Seeking Alpha